MRMD - MariMed GAAP EPS of $0.01 revenue of $35.8M beats by $0.7M; initiates FY23 guidance
- MariMed press release ( OTCQX:MRMD ): Q4 GAAP EPS of $0.01.
- Revenue of $35.8M (+15.3% Y/Y) beats by $0.7M .
- MariMed’s fiscal 2023 outlook is currently as follows: Revenue of $150+ million vs. consensus of $152.80M; Gross margin in line with full year 2022; Non-GAAP Adjusted EBITDA of $35+ million; Capital expenditures of $30 million.
For further details see:
MariMed GAAP EPS of $0.01, revenue of $35.8M beats by $0.7M; initiates FY23 guidance